TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PharmaSite AB
Closing information (x1000 EUR)
| Closing information | 2025/05 | 2024/05 | 2023/05 |
| Turnover |
270
|
500
|
265 |
| Financial expenses |
36
|
0
|
1 |
| Earnings before taxes |
-69
|
47
|
-174 |
| EBITDA |
-42
|
47
|
-173 |
| Total assets |
118
|
215
|
161 |
| Current assets |
116
|
213
|
159 |
| Current liabilities |
28
|
63
|
59 |
| Equity capital |
90
|
151
|
102 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
2
|
4
|
4 |
Financial ratios
| Fiscal year | 2025/05 | 2024/05 | 2023/05 |
| Solvency |
76.3%
|
70.2%
|
63.4% |
| Turnover per employee |
135
|
125
|
66 |
| Profit as a percentage of turnover |
-25.6%
|
9.4%
|
-65.7% |
| Return on assets (ROA) |
-28.0%
|
21.9%
|
-107.5% |
| Current ratio |
414.3%
|
338.1%
|
269.5% |
| Return on equity (ROE) |
-76.7%
|
31.1%
|
-170.6% |
| Change turnover |
-256
|
229
|
164 |
| Change turnover % |
-49%
|
85%
|
163% |
| Chg. No. of employees |
-2
|
0
|
0 |
| Chg. No. of employees % |
-50%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/05 | 2024/05 | 2023/05 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.